OccuLogix Inc. Provides Progress Update on the Commercial Development of Its TearLab(TM) Osmolarity System
TORONTO, ONTARIO--(Marketwire - October 15, 2008) - OccuLogix, Inc. (NASDAQ: OCCXD)(TSX: OC) provided an update today on the progress made by its wholly-owned subsidiary, OcuSense, Inc., in the commercial development of its TearLab™ Osmolarity System ("TearLab™").